Securities code: 301033 securities abbreviation: Medprin Regenerative Medical Technologies Co.Ltd(301033) Announcement No.: 2022-001 Medprin Regenerative Medical Technologies Co.Ltd(301033)
Suggestive announcement on the listing and circulation of offline placement restricted shares in the initial public offering
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Special tips:
1. The shares to be released this time are the offline placement restricted shares of the initial public offering. The number of shares to be released is 770487, accounting for 1.1663% of the total share capital after issuance. The restricted period is 6 months from the date of listing of Medprin Regenerative Medical Technologies Co.Ltd(301033) (hereinafter referred to as ” Medprin Regenerative Medical Technologies Co.Ltd(301033) ” or “the company”);
2. The listing and circulation date of the restricted shares is Wednesday, January 26, 2022. 1、 IPO offline placement shares
According to the reply on Approving the registration of Medprin Regenerative Medical Technologies Co.Ltd(301033) initial public offering (zjxk [2021] No. 1963) of China Securities Regulatory Commission and with the consent of Shenzhen Stock Exchange, the company issued 16515766 RMB common shares (A shares) for the first time and was listed on the gem of Shenzhen Stock Exchange on July 26, 2021. The total share capital of the company before the initial public offering is 49547185 shares, and after the initial public offering is 66062951 shares, including the total shares with limited sales conditions
51969248 shares, accounting for 78.6663% of the total share capital of the company; There are 14093703 tradable shares without sale conditions, accounting for 21.3337% of the total share capital of the company.
The restricted shares listed and circulated this time are the offline placement restricted shares of the company’s initial public offering. The restricted period is 6 months from the date of listing of the company’s shares. This part of the restricted shares totals 770487 shares, accounting for 1.1663% of the total share capital of the company after issuance. It will expire and be listed and circulated on January 26, 2022.
2、 Changes in the number of the company’s share capital since the formation of the restricted shares listed and circulated this time. The restricted shares listed and circulated this time belong to the offline placement restricted shares of the company’s initial public offering. Since the formation of the restricted shares of the company’s initial public offering, the company has not changed the number of share capital due to profit distribution, transfer of reserve, etc.
3、 Implementation of commitments by shareholders applying for lifting share restrictions
(I) application for lifting the commitment of restricted shareholders
According to the company’s announcement on initial public offering and listing on the gem, offline investors applying for lifting the restrictions on the sale of shares are subject to the following restrictions:
“The offline issuance part adopts the proportional sales restriction method, and the offline investors shall promise 10% of their allocated shares (rounded up) The sales restriction period is 6 months from the date of the issuer’s initial public offering and listing. That is, among the shares allocated to each placing object, 90% of the shares are sold indefinitely and can be circulated from the date when the issued shares are listed and traded on the Shenzhen Stock Exchange; The sales restriction period of 10% of the shares is 6 months, which shall be calculated from the date of listing and trading of the issued shares on the Shenzhen Stock Exchange. In this offering, the number of shares restricted to offline sales for 6 months is 770487, accounting for 1.17% of the total share capital after issuance. ” (Note: the proportion of the above-mentioned restricted shares in the total share capital after issuance is 1.1663% if four decimal places are retained)
In addition to the above commitments, there are no other shareholders of offline placement restricted shares applying for listing and circulation
Special commitment: there is no situation that the non performance of relevant commitments affects the listing and circulation of restricted shares.
(II) performance of share locking commitment
As of the disclosure date of this announcement, the shareholders holding the company’s offline placement restricted shares are within the restricted period
Strictly abide by the above commitments, and there is no failure to fulfill relevant commitments that will affect the listing flow of restricted shares this time
The situation of communication.
The shareholders applying for lifting the restrictions on sales do not occupy the funds of the listed company for non operating purposes
Under the circumstances, the company has no illegal guarantee for the above shareholders.
4、 The listing and circulation arrangement of restricted shares is lifted this time
(I) the number of restricted shares lifted this time is 770487 shares, accounting for% of the total share capital of the company
1.1663%；
(II) the listing and circulation date of the shares whose restrictions are lifted this time is January 26, 2022 (star)
Phase III);
(III) the number of shareholders whose restrictions on sales are lifted this time is 9140;
(IV) the details of the lifting of restrictions on the sale and listing of shares are as follows:
No. type of restricted shares proportion of the number of restricted shares held to the total share capital the number of restricted shares released this time remaining restricted shares / number of shares / number of shares / share
1 initial public offering offline 770487 1.1663% 770487 0
Placement of restricted shares
Note: the restricted shares are not pledged or frozen this time; The company lifted the restricted shares this time
Among the shareholders of the company, none of them are directors, supervisors or senior managers of the company at the same time, and none of them are former shareholders of the company
He has served as a director, supervisor or senior manager and has resigned for less than half a year.
5、 Changes in share capital structure before and after the release of restricted shares for listing and circulation
Before and after this change
Nature of shares proportion of number of shares (%) increase proportion of number of shares (%) (shares)
1、 Shares with limited sales conditions 51969248 78.6663 – 770487 51198761 77.5000
Of which: 49547185 75.0000 — 49547185 75.0000 restricted shares before the initial offering
Restricted shares after IPO 770487 1.1663 – 770487-
Restricted shares 1651576 2.5000 — 1651576 2.5000 can be lent after the IPO
2、 Shares without sale conditions 14093703 21.3337 770487 – 14864190 22.5000
3、 Total share capital 66062951 100.0000 — 66062951 100.0000
Note 1: the above data are based on the final handling results of China Securities Depository and Clearing Co., Ltd. Shenzhen Branch
Subject to.
Note 2: the “proportion” in this table is the result after rounding to four decimal places.
6、 Verification opinions of the recommendation institution
The sponsor Huatai United Securities Co., Ltd. issued restricted shares offline for the company’s initial public offering
The verification opinions of listed circulation are as follows:
After verification, Huatai United Securities believes that: the number of restricted shares lifted this time and the listing
The circulation time shall comply with relevant laws, administrative regulations, departmental rules, relevant rules and shareholders’ commitments.
The application for lifting the ban of tradable shares with limited sales conditions meets the relevant provisions, and the company and the restricted shares
The relevant information disclosure is true, accurate and complete. The sponsor’s solution to Medprin Regenerative Medical Technologies Co.Ltd(301033)
There is no objection to the listing and circulation of restricted shares.
7、 Documents for future reference
1. Application for listing and circulation of restricted shares;
2. Application form for listing and circulation of restricted shares;
3. Statement of share capital structure and detailed data sheet of restricted shares;
4. About Guangzhou Maipu Regenerative Medicine Technology Co., Ltd. of Huatai United Securities Co., Ltd
Verification opinions on the listing and circulation of offline placement restricted shares issued by the company.
It is hereby announced.
Medprin Regenerative Medical Technologies Co.Ltd(301033) board of directors January 21, 2022
